Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/3/2025

Diagnostic and Treatment Considerations for Cryptogenic Organizing Pneumonia

Diagnostic Criteria

  • The American Thoracic Society and European Respiratory Society guidelines characterize the organizing pneumonia pattern by a patchy process involving alveolar ducts and alveoli with or without bronchiolar intraluminal polyps 1
  • The 2020 ATS/JRS/ALAT guidelines require three features for a definitive histopathological diagnosis of nonfibrotic COP: cellular interstitial pneumonia, cellular bronchiolitis, and poorly formed nonnecrotizing granulomas 2

Treatment and Prognosis

  • The presence of Masson bodies confirms organizing pneumonia and predicts an excellent response to oral corticosteroids in the majority of patients, with typical initial dosing of prednisone ~50 mg/day 1, 3
  • Complete recovery occurs in the majority of patients, though relapse is common, reported in up to two-thirds of cases 1
  • The 5-year survival for cryptogenic OP is 73%, compared to 44% for secondary OP 4

Diagnostic Approach

  • Correlate biopsy findings with HRCT findings, including patchy migratory consolidation and reversed halo sign 1, 3
  • Confirm subacute presentation with median duration <3 months and symptoms such as cough, dyspnea, and fever 1, 3
  • Exclude secondary causes, including collagen vascular diseases, infections, malignancies, drug reactions, and hypersensitivity pneumonitis, before diagnosing cryptogenic OP 3, 5

REFERENCES

3

Diagnostic Workup and Treatment for Cryptogenic Organizing Pneumonia (COP) [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Organizing Pneumonia Diagnosis and Treatment [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

Organizing Pneumonia Causes and Associations [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025